LightDeck Diagnostics products

We are developing quantitative point-of-care, multiplex tests for hormones in blood.

We are developing point-of-care, multiplex tests for host-response biomarkers in blood.

We are developing a next generation test to assess patients with chest pain.

We are developing a test to detect antibodies to the SARS-CoV-2 virus.

We are developing a test to detect current infection by the SARS-CoV-2 virus.